BridgeMD
New treatment option for Transcranial Electric Stimulation
Official title Optimized and Personalized Trans-cranial Brain Stimulation in Partial Refractory Epilepsies
ClinicalTrials.gov ID: NCT06212609
What this study is testing
- What it's testing
- Epilepsy is one of the most common neurological diseases, affecting between 0.5% and 1% of the general population. Therefore, new diagnostic and treatment methods are having a big impact on society.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 18
You may be able to join if
- Any patient, male or female aged 1 to 18, with refractory partial epilepsy considered potentially surgical according to the definition of ILAE...
- Any epileptic patient with interictal epileptic spikes on his standard or High Resolution EEG and or on the Magnetoencephalography examination
- Any epileptic patient undergoing a structural MRI
- Any patient who has agreed to participate in the PerEpi 1 study allowing the optimization of the location of epileptic sources and the modelling of...
- Patients who have at least 4 seizures per month
You likely can't join if
- Patient not meeting the age criteria
- And/or presenting generalized epilepsy
- And/or presenting diffuse interictal peaks and/or presenting a serious alteration of the general condition and vital functions
- And/or in the event of refusal by one of the parents or the child
- Pregnant, parturient or breastfeeding woman.
- Contraindication to the use of mc-tDCS stimulation without seizure
The study team makes the final eligibility decision.
Where it's taking place
- Amiens, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 year to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amiens, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.